Logo image of NXU.DE

NEXUS AG (NXU.DE) Stock Fundamental Analysis

FRA:NXU - Deutsche Boerse Ag - DE0005220909 - Common Stock - Currency: EUR

68.6  -0.1 (-0.15%)

Fundamental Rating

6

Overall NXU gets a fundamental rating of 6 out of 10. We evaluated NXU against 12 industry peers in the Health Care Technology industry. NXU scores excellent points on both the profitability and health parts. This is a solid base for a good stock. NXU is valied quite expensively at the moment, while it does show a decent growth rate. With these ratings, NXU could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

NXU had positive earnings in the past year.
In the past year NXU had a positive cash flow from operations.
In the past 5 years NXU has always been profitable.
Each year in the past 5 years NXU had a positive operating cash flow.
NXU.DE Yearly Net Income VS EBIT VS OCF VS FCFNXU.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

1.2 Ratios

The Return On Assets of NXU (6.44%) is better than 63.64% of its industry peers.
Looking at the Return On Equity, with a value of 10.07%, NXU is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
NXU's Return On Invested Capital of 7.87% is fine compared to the rest of the industry. NXU outperforms 72.73% of its industry peers.
NXU had an Average Return On Invested Capital over the past 3 years of 8.04%. This is in line with the industry average of 7.76%.
Industry RankSector Rank
ROA 6.44%
ROE 10.07%
ROIC 7.87%
ROA(3y)6.13%
ROA(5y)6.06%
ROE(3y)10%
ROE(5y)10.43%
ROIC(3y)8.04%
ROIC(5y)7.97%
NXU.DE Yearly ROA, ROE, ROICNXU.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

The Profit Margin of NXU (10.25%) is better than 63.64% of its industry peers.
In the last couple of years the Profit Margin of NXU has grown nicely.
NXU's Operating Margin of 14.24% is fine compared to the rest of the industry. NXU outperforms 72.73% of its industry peers.
In the last couple of years the Operating Margin of NXU has grown nicely.
The Gross Margin of NXU (85.01%) is better than 72.73% of its industry peers.
In the last couple of years the Gross Margin of NXU has remained more or less at the same level.
Industry RankSector Rank
OM 14.24%
PM (TTM) 10.25%
GM 85.01%
OM growth 3Y8.72%
OM growth 5Y4%
PM growth 3Y2.83%
PM growth 5Y4.46%
GM growth 3Y-1.09%
GM growth 5Y-0.48%
NXU.DE Yearly Profit, Operating, Gross MarginsNXU.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NXU is still creating some value.
NXU has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, NXU has more shares outstanding
NXU has a better debt/assets ratio than last year.
NXU.DE Yearly Shares OutstandingNXU.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
NXU.DE Yearly Total Debt VS Total AssetsNXU.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 6.46 indicates that NXU is not in any danger for bankruptcy at the moment.
NXU's Altman-Z score of 6.46 is amongst the best of the industry. NXU outperforms 90.91% of its industry peers.
NXU has a debt to FCF ratio of 0.97. This is a very positive value and a sign of high solvency as it would only need 0.97 years to pay back of all of its debts.
NXU has a better Debt to FCF ratio (0.97) than 72.73% of its industry peers.
NXU has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.06, NXU is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.97
Altman-Z 6.46
ROIC/WACC1.16
WACC6.77%
NXU.DE Yearly LT Debt VS Equity VS FCFNXU.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 2.38 indicates that NXU has no problem at all paying its short term obligations.
NXU's Current ratio of 2.38 is fine compared to the rest of the industry. NXU outperforms 63.64% of its industry peers.
A Quick Ratio of 2.33 indicates that NXU has no problem at all paying its short term obligations.
NXU's Quick ratio of 2.33 is fine compared to the rest of the industry. NXU outperforms 63.64% of its industry peers.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 2.33
NXU.DE Yearly Current Assets VS Current LiabilitesNXU.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 12.99% over the past year.
The Earnings Per Share has been growing by 14.95% on average over the past years. This is quite good.
Looking at the last year, NXU shows a quite strong growth in Revenue. The Revenue has grown by 13.67% in the last year.
NXU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.09% yearly.
EPS 1Y (TTM)12.99%
EPS 3Y13.74%
EPS 5Y14.95%
EPS Q2Q%17.53%
Revenue 1Y (TTM)13.67%
Revenue growth 3Y14.01%
Revenue growth 5Y12.09%
Sales Q2Q%6.25%

3.2 Future

Based on estimates for the next years, NXU will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.69% on average per year.
Based on estimates for the next years, NXU will show a quite strong growth in Revenue. The Revenue will grow by 11.78% on average per year.
EPS Next Y8.29%
EPS Next 2Y11.72%
EPS Next 3Y12.87%
EPS Next 5Y15.69%
Revenue Next Year14.41%
Revenue Next 2Y12.27%
Revenue Next 3Y11.84%
Revenue Next 5Y11.78%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
NXU.DE Yearly Revenue VS EstimatesNXU.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100M 200M 300M 400M 500M
NXU.DE Yearly EPS VS EstimatesNXU.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0.5 1 1.5 2 2.5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 44.26, the valuation of NXU can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as NXU.
NXU's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 28.47.
A Price/Forward Earnings ratio of 35.61 indicates a quite expensive valuation of NXU.
The rest of the industry has a similar Price/Forward Earnings ratio as NXU.
Compared to an average S&P500 Price/Forward Earnings ratio of 92.74, NXU is valued rather cheaply.
Industry RankSector Rank
PE 44.26
Fwd PE 35.61
NXU.DE Price Earnings VS Forward Price EarningsNXU.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

NXU's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. NXU is more expensive than 63.64% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NXU is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 56.29
EV/EBITDA 17.74
NXU.DE Per share dataNXU.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates NXU does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of NXU may justify a higher PE ratio.
NXU's earnings are expected to grow with 12.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)5.34
PEG (5Y)2.96
EPS Next 2Y11.72%
EPS Next 3Y12.87%

More info and screens

4

5. Dividend

5.1 Amount

NXU has a yearly dividend return of 0.32%, which is pretty low.
Compared to an average industry Dividend Yield of 3.80, NXU has a dividend in line with its industry peers.
With a Dividend Yield of 0.32, NXU pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 0.32%

5.2 History

The dividend of NXU has a limited annual growth rate of 5.55%.
Dividend Growth(5Y)5.55%
Div Incr Years5
Div Non Decr Years5
NXU.DE Yearly Dividends per shareNXU.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.05 0.1 0.15 0.2

5.3 Sustainability

14.19% of the earnings are spent on dividend by NXU. This is a low number and sustainable payout ratio.
The dividend of NXU is growing, but earnings are growing more, so the dividend growth is sustainable.
DP14.19%
EPS Next 2Y11.72%
EPS Next 3Y12.87%
NXU.DE Yearly Income VS Free CF VS DividendNXU.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
NXU.DE Dividend Payout.NXU.DE Dividend Payout, showing the Payout Ratio.NXU.DE Dividend Payout.PayoutRetained Earnings

More info and screens

NEXUS AG

FRA:NXU (2/4/2025, 7:00:00 PM)

68.6

-0.1 (-0.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)N/A N/A
Inst Owners59.04%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.18B
Analysts69.09
Price Target70.76 (3.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.32%
Yearly Dividend0.21
Dividend Growth(5Y)5.55%
DP14.19%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.26%
Min EPS beat(2)2.01%
Max EPS beat(2)26.51%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.87%
Min Revenue beat(2)-4.27%
Max Revenue beat(2)-1.48%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.3%
PT rev (3m)2.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10.4%
EPS NY rev (3m)-10.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.02%
Revenue NY rev (3m)-1.02%
Valuation
Industry RankSector Rank
PE 44.26
Fwd PE 35.61
P/S 4.54
P/FCF 56.29
P/OCF 40.88
P/B 4.46
P/tB 18.17
EV/EBITDA 17.74
EPS(TTM)1.55
EY2.26%
EPS(NY)1.93
Fwd EY2.81%
FCF(TTM)1.22
FCFY1.78%
OCF(TTM)1.68
OCFY2.45%
SpS15.11
BVpS15.39
TBVpS3.78
PEG (NY)5.34
PEG (5Y)2.96
Profitability
Industry RankSector Rank
ROA 6.44%
ROE 10.07%
ROCE 10.88%
ROIC 7.87%
ROICexc 11.71%
ROICexgc 92.97%
OM 14.24%
PM (TTM) 10.25%
GM 85.01%
FCFM 8.06%
ROA(3y)6.13%
ROA(5y)6.06%
ROE(3y)10%
ROE(5y)10.43%
ROIC(3y)8.04%
ROIC(5y)7.97%
ROICexc(3y)11.32%
ROICexc(5y)10.74%
ROICexgc(3y)141.72%
ROICexgc(5y)139.19%
ROCE(3y)11.12%
ROCE(5y)11.02%
ROICexcg growth 3Y-3.18%
ROICexcg growth 5YN/A
ROICexc growth 3Y6.14%
ROICexc growth 5Y-0.61%
OM growth 3Y8.72%
OM growth 5Y4%
PM growth 3Y2.83%
PM growth 5Y4.46%
GM growth 3Y-1.09%
GM growth 5Y-0.48%
F-Score9
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF 0.97
Debt/EBITDA 0.27
Cap/Depr 41.58%
Cap/Sales 3.04%
Interest Coverage 250
Cash Conversion 51.51%
Profit Quality 78.63%
Current Ratio 2.38
Quick Ratio 2.33
Altman-Z 6.46
F-Score9
WACC6.77%
ROIC/WACC1.16
Cap/Depr(3y)39.43%
Cap/Depr(5y)37.17%
Cap/Sales(3y)3.18%
Cap/Sales(5y)3.36%
Profit Quality(3y)127.99%
Profit Quality(5y)145.71%
High Growth Momentum
Growth
EPS 1Y (TTM)12.99%
EPS 3Y13.74%
EPS 5Y14.95%
EPS Q2Q%17.53%
EPS Next Y8.29%
EPS Next 2Y11.72%
EPS Next 3Y12.87%
EPS Next 5Y15.69%
Revenue 1Y (TTM)13.67%
Revenue growth 3Y14.01%
Revenue growth 5Y12.09%
Sales Q2Q%6.25%
Revenue Next Year14.41%
Revenue Next 2Y12.27%
Revenue Next 3Y11.84%
Revenue Next 5Y11.78%
EBIT growth 1Y17.96%
EBIT growth 3Y23.95%
EBIT growth 5Y16.57%
EBIT Next Year73.91%
EBIT Next 3Y29.58%
EBIT Next 5Y26.82%
FCF growth 1Y-34.42%
FCF growth 3Y-6.47%
FCF growth 5Y10.73%
OCF growth 1Y-22.93%
OCF growth 3Y-0.59%
OCF growth 5Y8.48%